BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $10 Price Target

Benzinga · 3d ago
BTIG analyst Thomas Shrader reiterates NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains $10 price target.